Topical Finasteride Side Effects: What Research Shows

Last updated: Apr 20, 2026Fact CheckTopical FinasterideBased on 4 studies

This is a research-based fact check, not medical advice. The findings summarized here come from peer-reviewed studies and are presented without added opinions. Consult a certified healthcare practitioner before making any treatment decision.

Verdict

The most common side effects of topical finasteride are scalp reactions at the application site: redness, dryness, and itching. Sexual side effects are possible but rare; a real-world study of 638,629 men found them in 0.002% of users (Yu 2026). The FDA issued a warning in April 2025 citing 32 adverse event reports, several describing sexual dysfunction and mood changes that continued after stopping.

Key takeaways

  • Scalp reactions are the most common side effect: redness, dryness, itching, and irritation at the application site.
  • Sexual side effects are rare but confirmed: the FDA has logged reports of reduced libido, erectile dysfunction, and mood changes including depression.
  • Not FDA-approved: no topical finasteride product has gone through FDA approval. Compounded versions vary in concentration and quality.
  • The drug absorbs into the bloodstream: the FDA confirmed systemic absorption occurs, meaning body-wide side effects are possible, not just scalp reactions.
  • Most reported side effects persisted after stopping: this was noted in the majority of the 32 FDA adverse event reports.
Topical finasteride is not FDA-approved. The FDA issued an adverse event communication in April 2025 for compounded topical finasteride products, citing reports of sexual dysfunction and mood changes.

What are the side effects of topical finasteride?

Side effects fall into two groups: local reactions at the scalp, and systemic reactions from drug absorbed into the bloodstream.

Scalp reactions (most common)

These are caused by applying a liquid or spray to the skin and include redness, dryness or flaking, itching or stinging at the application site, and rash or contact dermatitis in a small number of users.

Systemic reactions (less common, more serious)

These happen when enough finasteride absorbs through the skin to affect the rest of the body. The FDA confirmed in its April 2025 alert that systemic absorption is expected, not theoretical. Reported systemic reactions include reduced sex drive, erectile dysfunction, difficulty ejaculating, depression, anxiety, brain fog, fatigue, insomnia, and testicular pain.

How common are topical finasteride side effects?

Based on available data, most users tolerate topical finasteride without significant side effects.

In the Yu 2026 real-world study of 638,629 men on a compounded topical finasteride and minoxidil product, 2.7% reported any side effect in a follow-up check-in. Sexual side effects specifically were reported by 12 patients (0.002%). No patient discontinued treatment due to side effects.

The Phase III clinical trial (Piraccini 2022) found that adverse event rates in the topical finasteride group did not differ meaningfully from the placebo group. No serious treatment-related adverse events occurred.

The Yu 2026 study was funded by Hims & Hers, whose employees conducted the research on their own product, and had a 24% check-in response rate. These numbers should be read as context, not proof.

Does topical finasteride cause sexual side effects?

Yes, it can, but the evidence suggests it happens far less often than with oral finasteride.

Clinical trials have not found a statistically significant increase in sexual side effects between topical finasteride and placebo groups. But the FDA's 2025 alert described 32 real-world cases of sexual dysfunction, including reduced libido, erectile dysfunction, and testicular pain, linked to compounded topical finasteride. Several of those cases reported symptoms continuing after stopping the product.

Why does this happen? Finasteride lowers DHT (dihydrotestosterone, the hormone that shrinks hair follicles). DHT also plays a role in sexual function and brain chemistry. When topical finasteride absorbs through the scalp into the bloodstream, it can reduce DHT throughout the body, which is the same mechanism behind oral finasteride's side effects. A Phase III trial found blood drug levels more than 100 times lower with topical vs oral use, meaning less systemic effect, but not zero.

Can topical finasteride cause depression or mood changes?

The FDA's 2025 alert specifically listed depression, anxiety, brain fog, and fatigue among the adverse events reported.

In the Yu 2026 real-world study, depression was reported by 13 of 638,629 patients (0.002%) and anxiety by 10 (0.002%). These rates are very low, but the study had no control group so they cannot be compared to a background rate. The mechanism is the same as for sexual side effects: DHT plays a role in brain chemistry, and reducing it systemically can affect some people in ways that are not yet fully understood.

What did the FDA say about topical finasteride in 2025?

In April 2025, the FDA issued a public alert about compounded topical finasteride products. Between 2019 and 2024, the FDA received 32 adverse event reports via its voluntary reporting system. Side effects included erectile dysfunction, decreased libido, depression, anxiety, brain fog, fatigue, insomnia, and testicular pain. In most cases these effects continued after stopping the product.

The FDA also flagged two additional risks specific to topical use. First, some prescribers had told patients the topical version had no risk of side effects at all, which the FDA described as misinformation. Second, topical finasteride can transfer to others through skin contact, which poses a risk for pregnant women as finasteride can cause birth defects in a male fetus.

If you use topical finasteride, keep the treated area away from others until it is fully dry, particularly pregnant women or women who could become pregnant.

Is topical finasteride safer than oral finasteride?

Clinical trial data suggests topical finasteride carries a lower risk of systemic side effects than oral finasteride, but it is not risk-free.

The reason is absorption. A Phase III trial found blood levels of finasteride were more than 100 times lower with topical vs oral use. Lower levels mean less DHT reduction throughout the body, which is where sexual and mood side effects originate. The Lee 2019 meta-analysis found men on oral finasteride 1mg were 66% more likely to report any sexual side effect than men on placebo. No equivalent signal has been found for topical finasteride in controlled trials.

That said, the FDA's 2025 warning and real-world reports from men who experienced persistent side effects show the risk is not eliminated by switching from a pill to a spray.

Evidence at a glance

StudyYearKey finding
Piraccini et al. - Phase III RCT topical finasteride spray2022No significant difference in adverse events vs placebo. Blood drug levels 100x lower than oral. Industry funded (Almirall).
Lee et al. - systematic review of topical finasteride20187 studies: no serious sexual side effects reported in any included study.
Yu et al. - 638,629 men real-world study2026Sexual side effects in 0.002% of users. Most common reactions: scalp irritation, dizziness. Industry funded (Hims & Hers); no control group.
Lee et al. - oral finasteride sexual side effects2019For context: oral finasteride 1mg showed 66% higher risk of sexual dysfunction vs placebo across 15 trials, 4,495 men.

What the research cannot tell you

  • Whether topical finasteride completely eliminates the risk of sexual side effects. No trial has been large enough or long enough to rule this out.
  • Why some users experience persistent side effects after stopping while most do not.
  • Whether compounded topical finasteride carries the same risk profile as a pharmaceutical-grade product. Concentration, vehicle, and quality vary by compounding pharmacy.
  • Long-term safety beyond 6 months. Most trials ran for 24 weeks only.
  • Whether any individual is at higher risk before they start.

Frequently Asked Questions